Compile Data Set for Download or QSAR
Report error Found 220 Enz. Inhib. hit(s) with all data for entry = 2867
TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383693(2-(6-(1-cyclobutyl-4-methylpiperidine-3-carbonyl)-...)
Affinity DataIC50: 1.12nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383699(US10280149, Example 184b)
Affinity DataIC50: 1.41nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383697(US10280149, Example 183d)
Affinity DataIC50: 1.53nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383703(2-(6-(1-cyclobutyl-4-isobutylpiperidine-3-carbonyl...)
Affinity DataIC50: 2nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383695(US10280149, Example 183b)
Affinity DataIC50: 2.06nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383705(2-(6-(1-cyclobutyl-4-isopropylpiperidine-3-carbony...)
Affinity DataIC50: 2.12nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383700(US10280149, Example 184c)
Affinity DataIC50: 3.13nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383650((1-cyclopropyl-4-ethylpiperidin-3-yl)(6-methoxynap...)
Affinity DataIC50: 4.90nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383634(US10280149, Example 140c)
Affinity DataIC50: 5.48nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383644((1-cyclobutyl-4-isobutylpiperidin-3-yl)(6-methoxyn...)
Affinity DataIC50: 5.60nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383688(2-(6-(1-cyclobutylpiperidine-3-carbonyl)-2-methoxy...)
Affinity DataIC50: 5.65nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383641(US10280149, Example 142d)
Affinity DataIC50: 6.56nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383635(US10280149, Example 140d)
Affinity DataIC50: 9.96nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383638(US10280149, Example 142a)
Affinity DataIC50: 11.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383668(6-(1-cyclobutyl-4-methylpiperidine-3-carbonyl)-2-n...)
Affinity DataIC50: 12.3nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383691(2-(2-methoxy-6-(4-methyl-1-propylpiperidine-3-carb...)
Affinity DataIC50: 12.3nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383546(2-[6-(1-cyclobutylpiperidine-3-carbonyl)-2-methoxy...)
Affinity DataIC50: 13.2nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383643(US10280149, Example 143b)
Affinity DataIC50: 15.9nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383711(3-[[4-cyclobutyl-2-(6-methoxynaphthalene-2-carbony...)
Affinity DataIC50: 22.3nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383541((6-methoxy-5-methyl-2-naphthyl)-(1-propyl-3-piperi...)
Affinity DataIC50: 26nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383717(4-[[4-cyclobutyl-2-(6-methoxynaphthalene-2-carbony...)
Affinity DataIC50: 30.9nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383544(2-[6-[1-(cyclopropylmethyl)piperidine-3-carbonyl]-...)
Affinity DataIC50: 33.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383543((1-cyclobutyl-3-piperidyl)-(6-methoxy-5-methyl-2-n...)
Affinity DataIC50: 39.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383545(2-[6-(1-cyclopentylpiperidine-3-carbonyl)-2-methox...)
Affinity DataIC50: 39.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383654((1-(cyclopropylmethyl)-4-methylpiperidin-3-yl)(5-h...)
Affinity DataIC50: 39.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383622((1-(cyclopropylmethyl)-4-methylpiperidin-3-yl)(5-m...)
Affinity DataIC50: 41.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383679((1-cyclobutylpiperidin-3-yl)(6-(methylsulfonyl)nap...)
Affinity DataIC50: 42.6nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383555((1-cyclobutyl-3-piperidyl)-[4-(1-hydroxyethyl)-2-n...)
Affinity DataIC50: 43.8nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383672(6-(4-methyl-1-propylpiperidine-3-carbonyl)-2-napht...)
Affinity DataIC50: 45.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383549((1-cyclobutyl-3-piperidyl)-[4-(hydroxymethyl)-2-na...)
Affinity DataIC50: 47.6nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383702(2-(6-(1-cyclobutyl-4-isobutylpiperidine-3-carbonyl...)
Affinity DataIC50: 53.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383694(US10280149, Example 183a)
Affinity DataIC50: 55.2nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383619((1-cyclobutylpiperidin-3-yl)(6,7,8,9-tetrahydro-5H...)
Affinity DataIC50: 55.3nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383707((1-cyclobutylpiperidin-3-yl)(5-(hydroxymethyl)-6-m...)
Affinity DataIC50: 55.3nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383505([(3S)-1-cyclopentyl-3-piperidyl]-(6-methoxy-2-naph...)
Affinity DataIC50: 56.6nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383557([1-(3,3-difluorocyclobutyl)-3-piperidyl]-(6-methox...)
Affinity DataIC50: 67.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383664(6-(1-(cyclopropylmethyl)piperidine-3-carbonyl)-2-n...)
Affinity DataIC50: 68.8nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383704(2-(6-(1-cyclobutyl-4-isopropylpiperidine-3-carbony...)
Affinity DataIC50: 70.1nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383624(US10280149, Example 137a)
Affinity DataIC50: 70.6nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383559([4-(1-hydroxyethyl)-2-naphthyl]-(1-propyl-3-piperi...)
Affinity DataIC50: 76.2nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383698(US10280149, Example 184a)
Affinity DataIC50: 77.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383696(US10280149, Example 183c)
Affinity DataIC50: 78nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383670(6-(1-cyclopentyl-4-methylpiperidine-3-carbonyl)-2-...)
Affinity DataIC50: 85.7nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383563(6-(1-cyclobutylpiperidine-3-carbonyl)-1-methyl-2-n...)
Affinity DataIC50: 87.5nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383609((5-(benzyloxy)naphthalen-2-yl)(1-(cyclopropylmethy...)
Affinity DataIC50: 90.9nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383561(1-methyl-6-(1-propylpiperidine-3-carbonyl)-2-napht...)
Affinity DataIC50: 91.8nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383625(US10280149, Example 137b)
Affinity DataIC50: 92.8nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383524([(3S)-1-(cyclopropylmethyl)-3-piperidyl]-(4-phenyl...)
Affinity DataIC50: 95.4nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383637((1-cyclobutyl-4-phenylpiperidin-3-yl)(6-methoxynap...)
Affinity DataIC50: 98.7nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

TargetLysine-specific demethylase 2B(Human)
Genentech

US Patent
LigandPNGBDBM383538(3-(1-cyclobutylpiperidine-3-carbonyl)naphthalene-1...)
Affinity DataIC50: 99.7nMAssay Description:Full length KDM2B was cloned, expressed, and purified to homogeneity. Compound inhibition of KDM2B demethylase activity was assessed by monitoring th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 220 total ) | Next | Last >>
Jump to: